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  Objective(s): The present day challenge is how to obtain germ cells from stem cells to treat patients 
with cancer and infertility. Much more efforts have been made to develop a procedure for 
attaining germ cells in vitro. Recently, human umbilical cord-derived mesenchymal stem cells 
(HUMSCs) have been introduced with higher efficacy for differentiation. In this work, we tried to 
explore the efficacy of HUMSCs and some effective products of placental cells such as transforming 
growth factors. This study is aimed to optimize a co-culture condition for HUMSCs with placental 
cells to obtain primordial germ cells (PGCs) and reach into oocyte-like cells in vitro. 
Materials and Methods: In this experimental study, HUMSCs and placental cells were co-cultured 
for 14 days without any external inducer in vitro. Then HUMSCs were assessed for expression of 
PGC markers; Octamer-binding transcription factor 4(OCT4), Tyrosine-protein kinase Kit (CKIT), 
Stage specific embryonic antigen 4  (SSEA4) , DEAD (Asp-Glu-Ala-Asp) box polypeptide 4( DDX4) 
and oocyte specific markers; Growth differentiation factor-9( GDF9), Zona pellucida glycoprotein 
3(ZP3). The pertinent markers were assessed by immunocytochemistry and Q-PCR. 
Results: Co-cultured HUMSCs with placental cells (including amniotic and chorionic cells) 
presented Oct4 and DDX4, primordial germ cells specific markers significantly, but increment in 
expression of oocyte-like cell specific markers, GDF9 and ZP3 did not reach to statistically 
significant threshold.   
Conclusion: Placental cell supplements Transforming growth factor (TGF α, β) and basic fibroblast 
growth factor (bFGF) in a co-culture model can provide proper environment for induction of 
HUMSCs into PGCs and expression of oocyte-like markers. 
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Introduction 
Based on World Health Organization reports, 
infertility is estimated as a common disease, which 
affected 14% of couples in fertile age in Europe. A 
national survey on family growth Americans in 2005 
reported that there was a 20% increase in American 
couples experiencing infertility between 1995 and 
2002. Another paper stated an increase from 42% to 
48.5% from 1990 to 2010 that may be related to 
delayed motherhood in the third decade of life and 
consequently resulted in decrease of oocyte quality 
in females. The short reproductive period in women 
can be even shortened if oocytes or granulosa cells 
are damaged following cancer treatments and as a 
result assisted reproductive techniques is required 
(1, 2).  
In recent years, stem cells can be considered as 
the potential solution for infertility problems by 
producing germ cells from stem cells.  Stem cells are 
undifferentiated cells that have the potential of self-
renewal and can give rise to specialized cells like 
germ cells that can be used for therapeutic purpose 
and in regenerative medicine (3). Recent studies 
explained that PGCs and gametes were derived from 
different types of stem cells such as embryonic stem 
cells (4-6), somatic stem cells like bone marrow and 
adipose tissue stem cells (7-10). However invasive 
methods for isolation of bone marrow, and  
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embryonic stem cells and ethical considerations for 
application of embryonic stem cells, provoked 
researchers to find alternative sources. Recently, 
scientists have found a new source of stem cells from 
birth-associated tissues like umbilical cord. Contrary 
to bone marrow and embryonic stem cells, isolation 
of HUMSCs from the umbilical cord and placenta of a 
newborn (11, 12) is non-complicated, without any 
risk of contamination, ethical issues and invasive 
methods (13, 14). 
HUMSCs can differentiate into cells of three 
embryonic layers, such as neuron (15-17), muscle, 
cartilage, hepatocyte, bone and cardiomyocyte (17). 
These cells and other neonatal associated tissues 
have a high efficacy to differentiate in comparison 
with other mesenchymal stem cells. In addition to 
their multipotent features, which are between that of 
adult and embryonic stem cells, it seems that these 
cells have high potential to differentiate into germ 
cells (19, 20). Therefor, establishment of an umbilical 
cord bank will be useful in the future for the 
preservation of newborns from cancer and infertility 
(21). They also have immunosuppressive and 
immunoprevilege properties owing to expression of 
HLA-G6, and these properties make them sufficient 
for allograft and even xenotransplantation of germ 
cells or gametes for infertility, cancer and chemo-
therapy in different stages of life (16, 19).  
Huang et al in 2010 tried to obtain HUMSC-
derived PGCs by using some inducers (20). Other 
scientists used growth factors, testicular conditioned 
medium, follicular fluid and gonadotropins and 
retinoic acid for various types of stem cells (8, 10, 11, 
22). In this work, we used placental cells, which 
some scientists named them human body “spare 
parts” (23) or universal feeder cells (24). Some 
works based on placental cells have shown                
some positive properties like expressing growth 
factors (TGFα, TGFβ, bFGF) (25-27), which are                 
all important factors for a micro-environment 
needed for cell proliferation, tissue regeneration, 
cellular differentiation, cellular transformation and 
regulation of the immune system (28, 29). These 
cells may provide proper condition for 
transplantation as they did not show tumorigenicity 
and adverse immunological responses (19). Human 
placental cells decrease the risk of zoonosis in 
culture location (30). So, from the above mentioned 
properties, placental cells including amniotic and 
chorionic cells can provide an appropriate micro-
environment for induction of HUMSCs. The aim of 
this study was to investigate the expression of PGC 
and oocyte like cell markers in HUMSCs. To 
accomplish this objective, we used placental cells to 
induce HUMSCs and to identify whether these cells 
were able to generate primordial germ cells and 
express principal oocyte-like cell markers in vitro.  
Materials and Methods 
Isolation and expansion of HUMSCs 
All the sampling procedures were performed 
according to ethical guidelines of Tehran University 
of Medical Sciences. Samples (umbilical cord and 
placenta) were utilized after informed written 
consent of parents. Samples of full-term and healthy 
female newborns after cesarean delivery were 
transferred to laboratory in HBSS (Hanks Balanced Salt 
Solution) on ice. All cell culture reagents were 
purchased form GIBCO, except those specified. HUMCs 
were isolated from umbilical cord using explant 
method (11). Amniotic membrane, arteries and vein 
were dissected out and the remaining Wharton’s jelly 
minced into small pieces. Wharton’s jelly fragments 
were plated in Dulbecco’s modified essential medium-
F12 supplemented with 10% FBS (Fetal Bovine Serum) 
and 100 units/ml penicillin-streptomycin and 
maintained in 37°C humidified incubator with 5% CO2. 
Cultures were allowed to migrate for 3 weeks. Migrated 
cells were sub-cultured by 0.25% Trypsin-EDTA and 
morphologically evaluated with inverted phase 
contrast microscope (Olympus CKX-41). Cells upon 80 
to 90% confluency were passaged and the medium was 
refreshed every other day. Cells from passages 3 to 4 
were utilized for differentiation studies.    
 
Differentiation into osteoblasts 
 HUMSCs were treated with osteogenic medium 
(Gibco-Invitrogen) for 21 days with twice a week 
medium change. The flasks were assessed every 3 days 
for osteogenesis. Osteogenesis progress was evaluated 
with Alizarin-red S staining. The cells were fixed with 
4% paraformaldehyde and stained with 1% Alizarin-
red S (Sigma-Aldrich) solution for 10 min. 
 
Differentiation into adipocytes: 
HUMSCs were treated with adipogenic medium 
(Gibco-Invitrogen) for 21 days and the medium was 
refreshed every 3 days. The cells were assessed 
every 3 days. Adipogenesis was evaluated by Oil Red-
O staining. Briefly, the cells were fixed with 4% 
paraformaldehyde and stained with Oil Red-O 
(Sigma-Aldrich) for 10 min and observed with 
inverted phase contrast microscope. 
 
Flowcytometry analysis  
Superficial markers of isolated cells in third passage 
were assessed. To this end, the cells were detached by 
0.25% Trypsin-EDTA and centrifuged at 1000 RPM for 
5 min. Cells were resuspended with phosphate buffered 
saline (PBS) to 106 cells per ml, and different aliquots 
were incubated with monoclonal antibodies against 
CD34-PE, CD45-FITC, CD29-PE, CD3-FITC, CD73-PE, 
CD90-FITC, CD105-FITC and human leukocyte antigen 
(HLA-FITC) for 30 minutes at 4°C in the dark. Isotype 
antibodies conjugated to FITC or PE were used for cell 
surface staining. Finally, cells were fixed with 1% 
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paraformaldehyde solution and analysed by Partec PAS 
III flowcytometry system, under Flomax software.  
 
Isolation and expansion of placental cells 
(chorionic and amniotic cells) 
After thoroughly wash in PBS, amniotic 
membrane was separated from chorionic plate, and 
tissues were separately incubated with 0.25% 
Trypsin-EDTA for 30 min followed by PBS wash. 
Afterward, enzymatic digestion was followed with 
0.05% collagenase 1 and 4 for 30 min and Dispase 2 
(2.5 mg/ml, Invitrogen) for 7 min. To remove tissue 
debris, cell suspension was filtered through 100 µm 
cell strainer. Cells were cultured in DMEM-F12 
supplemented with 10% FBS and 100 units/ml 
penicillin-streptomycin and maintained in 37◦C 
humidified incubator with 5% CO2.   
 
Co-Culture method 
To prepare for co-culture process, placental cells 
(included amniotic and chorionic cells) were 
inactivated by mitomycin-C (Sigma) for 3 hr and 
cultured in their medium overnight before further use. 
HUMSCs (passage 3) were cultured in the 6-well plates 
and placental cells (passage 3) plated on the 0.4 µm cell 
culture inserts (ThinCert - greiner) which provide a 
reciprocal and indirect co-culture system. Co-culture 
medium contained DMEM-F12 supplemented with 5% 
FBS (FBS – GIBCO). Half of the medium was refreshed 
every 2 to 3 days and the co-culture was continued for 
14 days. HUMSCs, which were treated with 1µm all-
trans retinoic acid (Sigma-Aldrich) for 6 days and 
cultured in DMEM-F12 and 2% FBS were served as 
control group for gene expression studies.   
 
Immunocytochemistry 
For immunofluorescent assay of germ-cell 
markers in HUMSCs, 14 days after co-culture, cells 
were washed with PBS and fixed in 4% 
paraformaldehyde at 4◦C for 10 min. Then, cells were 
washed 3 times with PBS and incubated in 0.1% 
Triton X-100 for 10 min. Non-specific binding sites 
were blocked with 5% goat serum for 45 min 
without washing followed by incubation with anti-C-
kit (abcam, Rabbit polyclonal anti-human, 1:100), 
anti-SSEA4 (abcam, Mouse monoclonal anti-human, 
1:100), anti-DDX4 (abcam, Rabbit polyclonal anti-
human, 1:100), anti-GDF9 (abcam, Rabbit polyclonal 
anti-human, dilution 1:200) antibodies for overnight 
at 4◦C. Then cells were washed with PBS and 
incubated with FITC-conjugated Goat Anti-Rabbit, 
(abcam, 1:50) or Goat Anti-Mouse (abcam, 1:200) for 
1 hr at room temperature. Nuclei were counter-
stained with DAPI (Sigma) for 5 min and observed by 
fluorescent microscope (Olympus, IX71). 
 
Quantitative PCR  
To isolate total RNA, Tri Pure reagent (Roche) was 
directly added to cells and processed per manufacturer 
instruction. Genomic DNA contamination was digested 
using RNase-free DNaes I (Thermo Scientific, Waltham, 
MA) for 30 min at 37:C. RNA concentration and purity 
were determined by spectrophotometric method (WPA 
spectrophotometer, Biochrom, UK). RNA was reversely 
transcribed by random Hexamer and 1000 ng of DNA-
free RNA using transcriptor first strand cDNA synthesis 
kit (Roche). TaqMan® Gene Expression Assays (Life 
Technologies) were recruited to study the expression of 
SSEA4, DDX4, GDF9  and ZP3, which normalized against 
18 sec expression as a housekeeping gene. PCR reaction 
mixture components for a final volume of 20 μl were as 
follows: 10 μl TaqMan® Universal Master Mix, 1 µl 
TaqMan® Assay reagent, 0.5 μl (25 ng) cDNA and 8.5 μl 
distilled water. PCR cycling parameters were set for 10 
min at 95:C (polymerase activation) and 40 cycles of 
95:C for 15 second and 60:C for 1 min using a Rotor-
Gene Q instrument (Qiagen). Using ΔΔCt method, 
relative expression of targets was calculated by 
normalizing Ct values of targets against 18 sec. 
 
Results 
Cell morphology 
Primary isolated cells from Wharton’s jelly 
fragments after first passage were spindle-shaped 
and revealed fibroblast-like morphology. HUMSCs 
possessed some long and short processes with high 
potential of proliferation (Figure 1, a-e). 
 
Flow cytometry findings 
 HUMSCs at passage 3 were assessed for their 
purity. They were mostly positive against mesenchymal 
stem cell markers, CD73, CD90, and CD105 and 
minimally reacted with CD34, CD45 (hematopoietic 
markers), CD14 (monocyte differentiation antigen), 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure1. A–D: The appearance of human umbilical cord derived 
mesenchymal stem cells. (a) The cells are migrating out from a 
piece of Wharton’s jelly (Black Arrow). (b) The cells after first 
passage forming their colonies. (c) The cells after third passage fill 
the bottom of flask. (d) Passage 4 co-cultured cells during 
differentiation at day 6. Magnification (40) 
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Figure 2. Osteogenic and adipogenic differentiation of human 
umbilical cord derived mesenchymal stem cells, (A, B) Cells in the 
osteogenic induction, prepared with Alizarin red staining after 21 
days of induction. (C) Cells in the adipogenic induction, prepared 
with Oil-red O staining after 21 days of induction. Magnification 
(20×, 40×) 
 
CD3 (T-cell co-receptor) and HLA (human leukocyte 
antigen). HUMSCs were 99.33%, 94.30%, and 87.22% 
positive for CD90, CD73 and CD105, respectively. 
Thecells also showed negligible presence for CD45 
(0.42%), CD34 (7.37%), CD14 (10.75%), CD3 (4.04%) 
and HLA (11.61%) (Figure 2, a-h). These results 
confirmed the purity of HUMSCs and ruled out the 
hematopoietic origin of isolated cells.  
 
Adipocyte and osteoblast differentiation 
HUMSCs after 21 days treatment with osteogenic 
and adipogenic differentiation medium stained 
positively with Alizarin Red-S for osteoblasts (Figure 
 
 
Figure 4.  Human umbilical cord mesenchymal stem cells 
expression of PGC and oocyte markers in co-culture condition 
relative to all-trans Retinoic acid treated human umbilical cord 
mesenchymal stem cells. OCT4 and DDX4 (PGC markers) revealed 
significant increase in co-culture condition (P-value<0.01 and              
P-value<0.05, respectively). GDF9 and ZP3 (oocyte marker) were 
up-regulated in co-culture but did not achieve statistical 
significance threshold  
 
3-a, b) and Oil Red-O for adipocytes (Figure 3-c).              
In addition, morphological changes corresponding to 
differentiated state of cells were detected.  
 
Immunocytochemistry findings 
HUMSCs after 14 days co-culture with placental 
cells presented strongly positive signal for PGC markers 
(SSEA4, C-kit and DDX4) , marker of oocyte-like cells 
and GDF9, (Figure 5, a-h) in immunofluorescent 
studies. Cells in control group also expressed the 
markers but with considerably weaker signal (data not 
shown).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Characteristics of human umbilical cord derived mesenchymal stem cells, Flow cytometric analysis of surface-markers 
expression. The cells after passage 3 were labelled with PE or FITC-conjugated antibodies. Cells were positive for CD105 (a), CD73 (b), CD 
90 (c), and negative for CD34 (d), CD45 (e), CD 14 (f), CD3 (g) and   HLA (h). Data were representative of three independent experiments 
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Figure 5. Immunocytochemistry analysis of human umbilical cord mesenchymal stem cells after 14 days co-culture with placenta cells 
(including amniotic and chorionic cells) for PGC specific markers; SSEA4 (a) nuclei in blue DAPI, (b) FITC positive cells, (c) merged view of 
SSEA4 positive cells. OCT4 (d) nuclei in blue DAPI, (e) OCT4 positive cells marked with FITC, (f) merged view of OCT4 positive cells. DDX4 
(g) nuclei in blue DAPI, (h) DDX4 positive cells marked with FITC, (i) merged view of DDX4 positive cells. GDF9 (j) nuclei in blue DAPI, (k) 
GDF9 positive cells marked with FITC, (l) merged view of GDF9 positive cells. Magnification: 40× 
 
 
Expression of primordial germ cells and oocyte-
like cells genes  
 HUMSCs after 14 days co-culture with the human  
placental cells (including chorionic and amniotic 
cells) compared to retinoic acid treated HUMSCs. So, 
RNA extraction and quantitative PCR for cells were 
performed. The cells were significantly increased the 
expression of primordial germ cells specific markers, 
OCT4 and DDX4, but the up-regulation of oocyte-like 
cell specific markers, GDF9 and ZP3, did not achieve 
to statistical significance threshold. Expression of 
Oct4 and DDX4 in co-cultured group was 9.8 and 6.5 
times higher compared to retinoic acid treated 
group, which showed significant trend P-value<0.01 
and P-value<0.05, respectively. However, 1.7 and 3.1 
times increment in expression of oocyte markers 
(GDF9 and ZP3) were not significant comparing to 
control group (Figure 4). 
 
Discussion 
In the present study, we reported that an 
innovative co-culture of placental cells can induce 
transition of HUMSCs into PGCs associated with 
expression of oocyte-like cells within 14 days by 
displaying special PGC markers such as OCT4, SSEA4, 
C-kit, DDX4 (VASA), and expression of oocyte-like 
cell special markers including GDF9 and ZP3 in vitro. 
To the best of our knowledge, this is the first study 
that determined the expression of above markers by 
induction of HUMSCs within 14 days of in vitro co-
culture with placental cells (including amniotic and 
chorionic cells) without any external inducer. It has 
been demonstrated that mesenchymal stem cells 
have more capability to differentiate than any other 
type of stem cells, but in our work HUMSCs from 
birth associated tissues was used, which has been 
reported to have a high efficacy to differentiate than 
any other mesenchymal stem cells from adult 
sources (19).  
HUMSCs showed high expression of OCT4, Nanog 
and SOX2 same as embryonic stem cells and also 
expressed CD29, CD44 and CD59 markers such as 
pluripotent adult stem cells (19, 33). It has been 
demonstrated that HUMSCs have a high proliferative 
potential in first passages, and they have 24 hours 
doubling time that preserved for 80 passages                  
(19, 34). It has been shown that HUMSCs were 
protected from immune rejection responses and 
their ability for immunocytes (T, B and neutral killer 
cells) activation suppressed; therefore, they have 
been considered as a suitable cell source for germ 
cell generating, cell therapy and transplantation (19). 
Asgari et al        Human Wharton’s jelly-derived mesenchymal stem cells
                                          
                             
 Iran J Basic Med Sci, Vol. 18, No. 1, Jan 2015   
 
27 
These properties discriminated HUMSCs from other 
stem cells. Our flowcytometry findings showed 
acceptable purity, and HUMSCs potential characterized 
in osteocyte and adipocyte differentiation. HUMSCs 
presented appropriate potential for differentiation into 
PGCs and expression of PGC markers such as SSEA4, 
OCT4, C-kit and DDX4 alongside with oocyte specific 
genes like GDF9 in immunocytochemistry findings. On 
the other hand, we showed that feeder cells from 
placenta including amniotic and chorionic stem                  
cells isolated from neonatal associated sources have 
higher differentiation potential and contain group of 
pluripotent stem cells that express OCT4, SOX2, SSEA4, 
and Nanog (19). Some researchers have reported               
that placental cells produce substances such as 
transforming growth factors α, βı, β2, β3 and basic 
fibroblast growth factor (bFGF) in their supplement 
(25). It has been shown that bFGF is capable to support 
the PGCs survival and motivates female pathway in 
reproductive system (26, 35). Also, three members of 
the TGFβ family (βı, β2, β3) are highly similar, and they 
are efficient proteins in cell proliferation, tissue 
regeneration, and cellular differentiation in most cells 
alongside with anti-apoptotic and anti-oxidative effects 
(36, 37). 
Our results based on recent studies revealed that 
human placental cells including amniotic and 
chorionic cells as a group of feeder cells have enough 
capability to induce differentiation of HUMSCs into 
germ cells and expression of oocyte like cells in co-
culture condition. This capacity of placental cells was 
indicated in Q-PCR results by obvious increase of 
PGC markers expression such as OCT4 and DDX4 and 
a lower expression of oocyte markers like GDF9 and 
ZP3 in comparison with retinoic acid treated group.  
In immunocytochemistry findings, the expression of 
SSEA4, C-kit, DDX4 and GDF9 protein markers were 
recorded. In our study, expression of genes and 
synthesis of protein markers in different developmental 
stages of germ cells were analyzed. SSEA4 (Stage 
specific embryonic antigen) is a pluripotency marker 
that also presents in human germ cells. OCT4 (Pou5f1) 
is a germ line-specific transcription factor, essential for 
primary stage of germ cell diagnosis and promotes 
germ cell survival and pluripotency (38, 39). C-kit is a 
migration and survival marker of PGCs that highly 
expressed by them, and a cell surface marker which 
binds to stem cell factor. DDX4 (VASA or DEAD Box 
Protein 4) is a pre-meiotic germ cell specific marker, 
which is an important protein in post migratory 
stage of primordial germ cells (22). GDF9 (growth 
differentiation factor-9) is known as the specific 
marker for oocyte recognition. ZP3 (zona pellucida 
producing gene- 3) is critical for oocyte construction; 
ZP proteins are markers of female germ cells and are 
detected in post-meiotic development (40). Recent 
works took the advantage of some inducers for 
induction of somatic stem cells to germ cells, utilizing 
retinoic acid. RA signaling was activated in bone 
marrow stem cells and induced meiosis and 
differentiation into spermatogonial-like cells (7). In 
the same line, follicular fluid and gonadotropins 
influenced fetal porcine skin stem cells and created 
oocyte-like cells (8), while others applied testicular 
cell conditioned medium for induction of embryoid 
bodies and produced immature oocyte-like cells (5). 
In another strategy, ovarian granulose cells                        
co-cultured with embryoid bodies for generating 
oocyte like cells (35). Based on the above findings, 
we used retinoic acid as an inducer for our treated 
group in Q-PCR, and applied co-culture method as a 
functional and useful method for induction of 
HUMSCs (35, 41).  We showed that co-cultured 
HUMSCs with placenta cells have higher capability of 
expressing PGC and oocyte-like cell markers. 
However, direct co-culture with cell-cell interaction 
may improve the expression of markers. Further 
studies should investigate HUMSCs derived PGCs 
features in more detail and appraise them in 
transplantation settings. We revealed that placental 
cells including amniotic and chorionic cells 
possessed effective role in differentiation of HUMSCs 
into PGCs and directed them toward oocyte-like cells. 
Parallel to previous studies, we thereby strengthen 
the fact that human umbilical cord mesenchymal 
stem cells have the capabilities to differentiate into 
germ line cells. 
 
Conclusion 
Finding novel inducers for differentiation of stem 
cells into germ cells is challenging. Herein, we 
introduced a co-culture system to induce HUMSCs 
into germ cells by secretory substances from 
placental cells, which may open a new avenue for 
induction methods in this interesting context.   
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